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  ABSTRACT 
 
BACKGROUND: Studies on cardiovascular risk factors among diabetic persons in Ethiopia are lacking. The 
objective of this study was to determine the prevalence of the cardiovascular risk factors (hypertension, obesity, 
physical inactivity, dyslipidemia and smoking) among diabetic patients at the diabetic clinic of Jimma 
University Specialized Hospital. 
METHODS: A cross-sectional study was conducted from October to December 2007. Three hundred one 
individuals were randomly selected from 950 patients on follow-up. Data were collected using a structured 
format and appropriate equipments and reagents. Laboratory data were recorded in a separate checklist. The 
data were entered into SPSS for Windows version 12. Multivariate regression analysis was carried out to 
identify predictors of hypertension, obesity and dyslipidemia. 
RESULTS: Two hundred and fifty six (85.1%) of the sample participated in the study. The prevalence of 
hypertension, obesity, dyslipidemia, physical inactivity and current smoking was 46.5%, 23.4%, 63.5%, 55.1% 
and 5.5% respectively. Age ≥ 45 years, type 2 diabetes and obesity were predictors of hypertension. Females 
were less likely to be hypertensive (OR =2.26, 3.37, 3.79 and 0.48 respectively). Type 2 diabetics and females 
were more while rural diabetics were less likely to be obese.  (OR =6.08, 4.17 and 0.37 respectively). Female 
gender, hypertension and fasting blood glucose ≥ 180mg/dl were predictors of dyslipidemia. Alcohol users were 
less likely to be dyslipidemic. (OR =4.25, 3.5, 3.56 and 0.39, respectively) 
CONCLUSION: Hypertension, obesity, dyslipidemia and physical inactivity were common while smoking was 
uncommon among diabetic patients in Jimma University Specialized Hospital. Type 2 DM was a predictor of 
hypertension and obesity. Diabetic women were more likely to be obese and dyslipidemic. We recommend 
screening and management of these risk factors. 
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INTRODUCTION 
 
The global burden of diabetes mellitus is rising 
dramatically. There are 230 million diabetic patients 
worldwide; two thirds of whom are in developing 
countries.  By the year 2030, more than 80% of the 
366 million diabetic patients will be in developing 
countries (1). In Ethiopia, national data on 
prevalence and incidence of diabetes are lacking. 
However, patient attendance rates and medical 
admissions in major hospitals are rising (2, 3). A 
population based study in northwestern Ethiopia 
(Gondar) showed an overall prevalence of diabetes 
and impaired glucose tolerance of 0.5%; a surprising 
low prevalence could be because most of the 
subjects were young (86%). Furthermore the 
prevalence of diabetes among older subjects (age > 
40 years) was higher (2.4%) (4). Moreover, Cohen et 
al reported a high prevalence of diabetes (8.9%) 
among young (age < 30 years) Ethiopian Jews who 
have been to Israel for less than 4 years (5).  
   Cardiovascular  diseases, i.e. Coronary heart 
diseases, stroke, and peripheral vascular diseases 
account for the majority of deaths in diabetic patients 
(6). Diabetes mellitus, hypertension, cigarette 
smoking, dyslipidemia, obesity and physical 
inactivity are established risk factors for 
cardiovascular diseases (CVD). These risk factors 
are known as traditional or conventional 
cardiovascular risk factors (6, 7). The conventional 
cardiovascular risk factors have greater impact on 
diabetic patients than non diabetics (6, 8). The 
multiple risk factors intervention trial (MRFIT) 
showed the presence of any one, two or all three risk 
factors (hypertension, cigarette smoking, 
dyslipidemia) increased the risk of CVD death more 
in diabetics than non-diabetic men (RR of 4.8, 4.0 
and 2.6, respectively)  (8). 
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Hypertension is common in diabetic patients 
especially type 2 diabetics (6, 9, 10, 11). There are 
variations in the prevalence of hypertension 
depending on the population and definition of 
hypertension (9, 10, 11).  Institution based studies in 
Addis Ababa and Jimma reported that about a third 
of diabetics are hypertensive (12, 13). Dyslipidemias 
(abnormal lipoprotein levels) are common in type 2 
(6, 9, 10, 11) but not in type 1 diabetics if the latter 
are under good glycemic control (6, 14). Obesity is 
also more common among type 2 diabetics (9) and is 
associated with dyslipidemia and hypertension (6, 
15). In the west, up to 25% of diabetic patients 
smoke cigarettes (9, 10).  
   In Ethiopia, studies on the cardiovascular risk 
factors and complications of diabetes are lacking. A 
retrospective study in Tikur Anbesa Hospital showed 
that CVDs were responsible for 16% of deaths 
among diabetic admissions 2
nd to acute 
complications and infections that caused 18% of 
deaths (3).  
In view of the growing burden of diabetes and its 
cardiovascular complications in the developing 
world, it is crucial to determine the physical and 
metabolic characteristics of diabetic persons in this 
part of the world.  This study was conducted to 
assess the prevalence of cardiovascular risk factors 
among diabetic patients on follow-up at the diabetic 
clinic of Jimma university specialized hospital. 
 
METHODS AND MATERIALS 
 
This cross-sectional study was conducted at the 
diabetic follow-up clinic of Jimma University 
Specialized Hospital (JUSH) located in Jimma City, 
357 km southwest of Addis Ababa. The hospital is a 
referral centre for the South-Western part of 
Ethiopia. The study was carried out from October to 
December 2007. 
   The study population was all adult (≥18 years) 
diabetic patients who were on follow-up at the 
diabetic clinic of JUSH registered till June 31, 2007. 
Pregnancy and acute illness were the exclusion 
criteria. 
   The sample size was determined using EPI-
Info statistical software for estimating single 
population proportion. A total of 950 diabetic 
patients constituted the source population. The 
assumptions considered during calculation of the 
sample size were: 50% prevalence of CVD risk 
factors, 95% confidence level and margin of error of 
5%. The final sample size with 10% non-response 
was 301. The patient registration book contains all 
diabetic patients ever enrolled for follow up at the 
clinic. The serial numbers of the patients who were 
on follow up, eligible, and not involved in the pretest 
were taken and the sample drawn using the lottery 
method.   
Data were collected using a pretested structured 
format and a separate checklist for laboratory results. 
The format and checklist were linked by unique 
identification code (ID). 
   The data collection format had four parts. The 
first section was concerning socio-demographic 
characteristics. The second section was about habits 
including cigarette smoking, alcohol consumption, 
coffee drinking, exercise and diet. The third part was 
for clinical data including age at diagnosis, duration 
and treatment (current and initial) of diabetes; 
history of hypertension and its treatment. In the final 
part weight, height, BMI, waist circumference, and 
blood pressure were recorded. Weight was measured 
in kilograms (kg) using the WHO weighing scale 
(Health-O-Meter, USA) at a precision of 0.1kg with 
the study subjects minimally dressed. Height was 
measured in centimeter (cm) in erect position at a 
precision of 0.1cm with shoes removed. Waist 
circumference was measured in cm at the midpoint 
of the line between the lowest border of the thoracic 
cage and anterior superior iliac spine. Blood pressure 
was measured using a mercury sphygmomanometer 
with a cuff deflation rate of 2mmHg. Measurements 
in each arm after 10 min in sitting position were 
averaged to be recorded. 
   For laboratory measurements, blood was taken 
at the clinic after an overnight fasting of 10-14 
hours. The patients attending the clinic were advised 
to come after an overnight fasting for the 
determination of FBG and lipid profiles. Urine 
samples were also obtained. FBG, serum total 
cholesterol, HDL-C and triglyceride were 
determined using the hemanalyzer machine (Human, 
USA) and appropriate reagents. LDL-C was 
calculated using the Freidwald formula (6, 14). 
Urine dipstick was done for presence of albuminuria.  
    The interview, chart review and physical 
measurement were carried out by trained medical 
interns. Laboratory samples were collected by an 
experienced nurse working at the diabetic clinic. 
Laboratory analyses were carried out by a laboratory 
technician. A first year medical resident supervised 
the data collection process at the clinic. The 
laboratory data collection and analysis was 
supervised by a senior laboratory technologist. 
   To ensure quality, pre-test was conducted on 
30 patients, training was given to data collectors and 
supervisors on the data collection process and the 
collected data were checked for completeness and 
consistency on the day of collection.                         Risk Factors for Cardiovascular Diseases                                     Solomon T. et al 
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    The collected data were entered in to computer 
and analyzed using SPSS for windows version 12.1. 
The prevalence of hypertension, obesity, 
dyslipidemia, smoking and physical inactivity was 
determined. We employed multivariate regression to 
identify predictors of hypertension, obesity, and 
dyslipidemia.  
During data analysis some variables were 
categorized into meaningful categories. Type 1 DM 
was defined as age at onset of diabetes < 30 years or 
insulin treatment from diagnosis. Type 2 DM was 
defined as age at onset ≥ 30 years and initial 
treatment with oral agents (6). Systemic 
hypertension, obesity, dyslipidemia and smoking 
were the conventional risk factors for CVD (6, 7). 
Hypertension was defined as systolic blood pressure 
(SBP) > 140mmHg or diastolic blood pressure > 90 
mmHg  or being on treatment for a physician 
diagnosed hypertension. Obesity was defined as 
BMI > 30kg/m
2 or waist circumference > 102 cm for 
men and >  88 cm for women. A patient was 
considered to have Dyslipidemia in the presence of 
at least 1 of the following: high plasma total 
cholesterol (>200mg/dl), high LDL-C (>130mg/dl), 
low HDL-C (<40mg/dl in men or < 50mg/dl in 
women), high triglyceride level (>150mg/dl) (16, 
17). A person who smokes any quantity of cigarette 
in the last 12 months was labeled as current smoker 
(7). A person who reports regular aerobic exercise 
(walking, jogging) of at least 30 min for every 5 
days or its equivalent; or whose occupation requires 
physical exertion daily was considered to be 
physically active. (17). Macroalbuminuria was 
defined as detection of albumin in the spot urine 
specimen (6). 
    The study was approved by the ethical 
clearance committee of Jimma University. Each 
participant was informed in detail and his/her 
consent was obtained before data collection. Patients 
who were identified to have hypertension were 
informed and managed accordingly. 
 
RESULTS 
 
Out of the 301 randomly selected study subjects, 256 
(85.1%) participated in the study.  
The mean age of the study participants was 45.3 ± 
14.6 years and 125 (48.9%) were younger than 45 
years. A hundred and fifty nine (62.1%) were men 
and 153 (59.8%) of the respondents were urban 
residents. Eighty nine (34.8%) were illiterate while 
102 (39.8%) had primary education. Sixty eight 
(26.6%) were farmers (Table 1). 
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Figure 1. Frequency of multiple CVD risk factors (hypertension, obesity, dyslipidemia, smoking) in diabetic 
patients, JUSH, Oct - Dec 2007 (n = 197) 
 
Type 2 diabetes accounted for 171 (66.8%) and the 
rest were type 1 diabetics. The mean duration of 
diabetes was 5.83 ± 5.42 years. In 129 (50.4%) of 
the study subjects, duration of diabetes was less than                         Ethiop J Health Sci.                           Vol. 20, No. 2                             July 2010 
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5 years while only 45 had diabetes for 10 or more 
years. Only 66 (25.8%) participants had FBG below 
126 mg/dl while 42 (16.4%) had a FBG of 250 mg/dl 
or more. Albuminuria was detected in 99 (38.8%) of 
the respondents (Table 1). 
 Of one hundred and nineteen (46.5%) hypertensive 
participants, 41 (34.5%) were undiagnosed. Sixty 
(23.4%) of the participants were obese. Of 197 
participants whose lipid levels were determined, 125 
(63.5%) were dyslipidemic. Low HDL–C was the 
commonest lipid abnormality, found in 99 (50.2%) 
of the participants. Smoking is the least frequent risk 
factor (Table 2). 
 
Table 1. Baseline characteristics of diabetic patients on follow up at JUSH, Oct - Dec, 2007. 
 
 
Variables 
 
 
Number 
(n=256) 
 
Percent 
Socio-demographic 
 characteristics 
 
Age   < 45 years 
> 45 years 
125 
131 
48.9 
51.1 
Gender  Male 
Female 
159 
97 
62.1 
37.9 
Address Urban 
Rural 
153 
103 
59.8 
40.2 
Education  
Illiterate 
Grade 1-8 
Grade 9-12 
Tertiary 
89 
102 
44 
21 
34.8 
39.8 
17.2 
8.2 
Occupation 
Farmer 
House wife 
Employee 
Merchant 
Laborer 
Pensioner 
Others 
68 
73 
34 
22 
20 
14 
25 
26.6 
28.5 
13.3 
8.6 
7.8 
5.5 
9.8 
Other baseline variables  
 
Alcohol use      
No 
Yes 
193 
63 
75.4 
24.6 
Chat chewing    
No 
Yes 
195 
61 
76.8 
23.2 
Diabetes     Type 
1 
Type 2 
85 
171 
33.2 
66.8 
DM Duration  < 5 
(in years)         5-
9.9 
> 10 
129 
82 
45 
50.4 
32.0 
17.6 
Current treatment  
Oral 
Insulin 
125 
131 
48.8 
51.2 
FBG (mg/dl)  < 
126 
126-179.9 
180-249.9 
> 250 
66 
79 
69 
42 
25.8 
30.4 
27.0 
16.4 
Albuminuria  No 
Yes 
157 
99 
61.3 
38.7 
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Among the 197 participants for whom all 
measurements were available, 153 (77.7%) had at 
least one of the four risk factors (hypertension, 
obesity, dyslipidemia, smoking). Seventy (35.5%) 
had only one risk factor while 30 (15.3%) had 3 or 
four factors (Fig. 1). 
 Age, gender, type of DM and obesity were found to 
be independently associated with hypertension. 
Hypertension was more than two times likely in 
those with age 45 years or older (OR=2.26, 95% CI; 
1.06-4.82), three times in type 2 diabetics (OR=3.37, 
95% CI; 1.16-8.18) and nearly four times in obese 
(OR=3.79, 95% CI; 1.72-8.36) patients than their 
respective counterparts.  Females were 48% as likely 
to be hypertensive (OR=0.48, 95% CI; 0.23-0.99) as 
males. Address, educational status, duration of 
diabetes, type of treatment for diabetes, physical 
activity, smoking, alcohol use and chat chewing 
were not significantly associated with hypertension 
(Table 3).
 
 
Table 2. CVD risk factors among diabetic patients on follow up at JUSH, Oct - Dec, 2007.  
 
 
CVD risk factors  Number  Percent 
Hypertension 119  46.5 
Obesity 60  23.4 
Dyslipidemia (n = 197)  125  63.5 
Current Smoking  14  5.5 
Physical inactivity  141  55.1 
 
Type 2 diabetes and the female gender were the 
strongest independent predictors of obesity with OR 
(95% CI) 6.08(1.52-24.23) and 4.17(1.94-8.97) 
respectively. Rural subjects were 37% as likely to be 
obese as urban residents with (OR=0.37, 95% CI; 
0.16-0.87). Other factors were not found to have 
significant association with obesity (Table 3). 
   Gender, FBG level, hypertension and alcohol 
use were independently associated with 
dyslipidemia. Dyslipidemia was more than four 
times common in females compared to males (OR = 
4.25, 95% CI; 1.69-10.68). FBG level ≥ 180mg/dl 
was associated with nearly fourfold risk of 
dyslipidemia compared to lower levels. 
Hypertension also increased the risk of dyslipidemia 
by more than three fold (OR = 3.5, 95% CI; 1.55 – 
7.90). Patients who drink alcoholic beverages were 
less likely to be dyslipidemic compared to those who 
didn’t (OR = 0.39, 95% CI; 0.17-0.89). Other factors 
were not independently associated with dyslipidemia 
(Table 3). 
 
DISCUSSION 
 
Hypertension, obesity and dyslipidemia were 
common among diabetic patients in JUSH while 
cigarette smoking was uncommon. More than three 
fourth of the diabetic patients had at least one of the 
above cardiovascular risk factors. Age ≥ 45, type 2 
DM, and obesity were predictors of hypertension. 
Type 2 DM and female gender predict obesity.   
Female gender, hypertension and FBG ≥ 180 mg/dl 
were predictors of dyslipidemia.  
   The prevalence of hypertension in this study is 
higher than the one reported (36.3%) among diabetic 
patients in JUSH in 2005 (13). This difference could 
be due to the inclusion of under 18 diabetics in the 
previous study. In our study, more than a third of the 
hypertensives were undiagnosed. Blood pressure was 
controlled in only 9.2% of all hypertensive cases. 
This is lower than findings in other studies carried 
out in USA (31%) and Spain 35% (9, 15, 18). This 
difference can be explained by differences in the 
study settings. 
   In this study; age ≥ 45 years, type 2 DM and 
obesity were positive predictors of hypertension 
consistent with findings from other studies (9, 10, 
11, 18, 19).  In the USA, 19.4% of type 1 and 74 % 
of type 2 diabetics had hypertension (9). The 
Diabetes in Germany (DIG) study showed the strong 
association of hypertension and obesity among type 
2 diabetic individuals (p<0.001) (10).  
    Central obesity was more than twice as 
frequent as overall obesity (BMI>30 kg/m2) in this 
study. BMI of all of the obese individuals (by waist 
circumference) was > 25 kg/m2. Since overweight 
individuals with central obesity have similar CVD 
risks as those with BMI of 30- 34.9 kg/m2 (20), 
considering them obese is appropriate.  Jansen et al 
have shown that obesity related health risks are 
explained by waist circumference and not BMI (21). 
Many studies have shown that waist circumference 
predicts CVD risk similar to Waist to Hip Ratio 
(WHR) (20, 21, 22) and better than BMI and some 
point out that its simplicity makes it more useful 
than WHR (22).                          Ethiop J Health Sci.                           Vol. 20, No. 2                             July 2010 
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In our study, 23.4% of the participants were obese 
which is lower than  the NHANES III report where 
51.6% of type 2 diabetics were obese (9). Other 
studies have also demonstrated that obesity is 
common in type 2 DM (10, 19, 23). Comparison is 
difficult because of the difference of the study 
subjects and definitions of obesity. However our 
study showed the association between type 2 DM 
and obesity consistent with other studies (9, 10, 23). 
  Female gender and type 2 DM were found to be 
positive predictors of obesity while rural residence 
was protective.  The association between the female 
gender and obesity among diabetics is consistent 
with other studies (9, 10, 19, 23). The lower risk of 
obesity among rural residents can be explained 
epidemiologic transition that results from 
urbanization (24). 
 
Table 3. Multivariate analysis of the associations between selected characteristics and the CVD risk factors in 
diabetic patients, JUSH, Oct - Dec, 2007. 
 
Independent variables  Hypertension 
OR(95% CI) 
Obesity 
OR (95% CI) 
Dyslipidemia 
OR (95% CI) 
Age in years  < 45 
≥ 45 
1 
2.26(1.06-4.82) 
1 
1.04(0.44-2.42) 
1 
0.99(0.36-2.74) 
Gender Male 
Female 
1 
0.48(0.23-.99) 
1 
4.17(1.94-8.97) 
1 
4.25(1.69-10.68) 
Address Urban 
Rural 
1 
0.59(0.28-1.22) 
1 
0.37(0.16-0.87) 
1 
0.99(.39-2.53) 
Education   ≤ Primary 
> Primary  
1 
0.84(0.38-1.86) 
1 
0.63(0.26-1.53) 
1 
1.16(0.45-3.00) 
Type of DM  Type 1 
Type 2 
1 
3.37(1.16-8.18) 
1 
6.08(1.52-24.23) 
1 
1.68(0.48-5.89) 
Duration of diabetes  < 5 years 
≥ 5 years 
1 
1.28(0.69-2.36) 
1 
1.02(0.49-2.10) 
1 
0.55(0.26-1.17) 
Current treatment  Oral anti-DM 
Insulin 
1 
0.99(0.45-2.17) 
1 
1.06(0.47-2.41) 
1 
0.61(0.23-1.62) 
FBG level  < 180mg/dl 
≥ 180mg/dl 
1 
0.75(0.41-1.38) 
1 
0.56(0.27-1.16) 
1 
3.56(1.67-7.63) 
Chat chewing  No 
Yes 
1 
0.92(.43-1.99) 
1 
1.49(0.57-3.89) 
1 
1.45(0.60-3.51) 
Alcohol use  No 
Yes 
1 
0.77(0.37-1.60) 
1 
0.89(0.38-2.08) 
1 
0.39(0.17-0.89) 
Physical activity  Yes 
No 
1 
1.4(0.72-2.73) 
1 
2.05(0.89-4.74) 
1 
1.45(0.64-3.26) 
Current smoking  No 
Yes 
1 
0.32(0.07-1.45) 
1 
0.78(.08-7.43) 
1 
2.09(0.39-11.3) 
Obese No 
Yes 
1 
3.79(1.72-8.36) 
* 1 
0.85(.29-2.50) 
Hypertension No 
Yes 
* *  1 
3.5(1.55-7.90) 
* - not applicable 
 
 
Nearly two-thirds of the participants were 
dyslipidemic. Low HDL-C and elevated triglyceride 
were more frequent while raised total cholesterol and 
LDL-C were less common. The high prevalence of 
dyslipidemia might be due to poor glycemic control 
among our study subjects. Poor glycemic control is                        Risk Factors for Cardiovascular Diseases                                     Solomon T. et al 
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associated with low HDL-C level and 
hypertriglyceridemia (6, 25).  Compared to the study 
conducted at Tikur Anbesa Hospital (TAH) in 2003 
where cholesterol level was elevated in almost half 
of the patients (26), our study showed lower 
frequency of elevated total cholesterol level.  The 
difference may be due the fewer number of diabetic 
patients (100) included in the TAH study.  
 Female gender, hypertension and FBG ≥ 180 mg/dl 
are positive predictors for dyslipidemia. The 
association of dyslipidemia with female gender (6, 9) 
and poor glycemic control is consistent with other 
studies (25).  We don’t have any explanation for the 
association observed between hyperetension and 
dyslipidemia which requires further research. 
Alcohol users were less likely to be dyslipidemic. 
This might be because alcohol increases the level of 
HDL-C (16). However, further studies are needed to 
clarify this finding. 
This study has several limitations. Since it is hospital 
based, the findings may not be applicable to the 
general population. Errors of measurement are 
possible but we have used training, pretest and 
supervision to ensure data quality. Hypertension and 
dyslipidemia might be overestimated by use of 
single measurement but we used standard 
operational definitions.  
    We recommend routine screening and 
management of hypertension, obesity, and 
dyslipidemia for diabetic patients in JUSH. Further 
studies aimed at assessing the impact of these CVD 
risk factors are needed. Similar studies in the 
community setting are needed.  
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